Scientific Advisors

Scientific advisors

Dr Kaustuv Bhattacharya

Specialist Metabolic Paediatrician

Dr Kaustuv Bhattacharya is a paediatrician trained in the United Kingdom. His metabolic training was in London at Great Ormond Street Hospital for Children.

Having completed a fellowship in metabolic medicine and newborn screening in Sydney, he completed clinical research in glycogen storage diseases with the late Dr. Philip Lee and obtained a research MD in clinical nutrition for this work from the University of London. His work also led to a new carbohydrate therapy for glycogen storage disease being developed and marketed.

The Charles Dent Metabolic Unit, at The National Hospital for Neurology and Neurosurgery London is a large adult clinical metabolic service and Dr Bhattacharya was involved in the management of the 1500 adults in this clinic. He moved to Sydney, Australia in June 2008, where he is now practicing as a specialist paediatric metabolic physician.

He is continuing clinical research projects in several inborn errors of metabolism, allied to the NSW newborn screening programme and is the principal investigator for 2 clinical trials. He has published over 20 papers in peer-review journals and continues to collaborate widely with various centres across the world. In Australasia he is known for his inclusive approach to engagement with peers.

He is a committee member of the International Congress of Inborn Errors of metabolism scientific programme committee for Rio de Janeiro in 2017 and successfully led the bid for the same meeting to be hosted in Sydney in 2021, for which he will be chair of the local organising committee.

Dr Andrew Morris

Consultant Paediatrician

Dr Andrew Morris is a Consultant and Senior Lecturer in Paediatric Metabolic Medicine. He works on the Willink Metabolic Unit, which is part of Genomic Medicine in the Central Manchester University Hospitals. This unit has 6 consultant metabolic paediatricians and provides a service to the North of England through a clinical network.

Dr Morris has been a consultant since 1996 first in Newcastle-upon-Tyne and then at Great Ormond Street Hospital in London, before moving to Manchester in 2003. He has extensive experience of inborn errors of metabolism in children and some experience with adults. His research has primarily concerned the diagnosis and management of mitochondrial disorders and fatty acid oxidation defects. He has considerable experience of managing patients with classical homocystinuria and remethylation disorders.

He is on the Steering Group for E-HOD, the European Network and Registry for Homocysinurias and Methylation Defects; he is Leader of the Classical Homocystinuria Guidelines Group and the Work Group on Evaluation of the Project.

Professor Bridget Wilcken

AM, MD, FRACP, FRCPA (hon), FHGSA

Professor Bridget Wilcken has spent her professional life in the diagnosis and clinical care of individuals affected by metabolic disorders, and also has had extensive research interests in this area, in particular in homocystinuria.  She is internationally recognized both for her contributions to the inborn errors field and to newborn screening.
Her early research interests saw her focus on homocystinuria and the clinical features and diagnosis of this in Australia. She was prominent in the introduction of betaine as a treatment in pyridoxine-non-responsive cases of homocystinuria.  It is without a doubt that her research outcomes have resulted in an improvement in the quality of life of individuals affected by the disease.

Professor Wilcken is a founding member of the Australasian Society for Inborn Errors of Metabolism, contributed substantially to the founding and organisation of the International Society for Neonatal Screening, has served on committees of professional organisations, authored numerous publications and several book chapters and given invited presentations both on metabolic diseases and newborn screening worldwide.   She has a university appointment as Clinical Professor in the Discipline of Paediatrics, University of Sydney and was Clinical Director of the New South Wales Biochemical Genetics and Newborn Screening Services at the Children’s Hospital at Westmead.

She graduated in medicine from Edinburgh in 1956 and worked in Edinburgh and London before coming to Sydney, Australia.  She is former President of the Human Genetics Society of Australasia, the International Society for Neonatal Screening (ISNS), and the Australasian Society for Inborn Errors of Metabolism, and former chair of the Genetics Services Advisory Committee for New South Wales. In 2002 she was awarded the Order of Australia and in 2004 the Guthrie Medal of the ISNS for services to newborn screening.